Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Clinical trial NCT06526793 · RECRUITING

Trial details

NCT number: NCT06526793
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

B-cell Non-Hodgkin Lymphoma Follicular Lymphoma (FL)Large B-Cell Lymphoma (LBCL)

Start date: 2024-11-27
Primary completion: 2028-04-21
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.